Investor profile
CTI Life Sciences has backed 3 European tech companies across 3 funding rounds between 2022 and 2023, joining rounds totalling €181M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Amolyt Pharma | France | 1 | €129M |
| Domain Therapeutics | France | 1 | €40M |
| Epitopea | UK | 1 | €12M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Domain Therapeutics | Series A | €40M | 2022-05 |
| Epitopea | Seed | €12M | 2022-04 |
